关注
Kehinde Sulaimon Ayinde
Kehinde Sulaimon Ayinde
PhD student (Biochemistry, Biophysics and Molecular Biology) , Iowa State University
在 iastate.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on In silico perspective
ID Boyenle, UC Divine, R Adeyemi, KS Ayinde, OT Olaoba, C Apu, L Du, ...
Pharmacological Research 167, 105577, 2021
292021
Neurotrophic, anti-neuroinflammatory, and redox balance mechanisms of chalcones
TI Adelusi, GR Akinbolaji, X Yin, KS Ayinde, OT Olaoba
European Journal of Pharmacology 891, 173695, 2021
212021
AMPK allostery: a therapeutic target for the management/treatment of diabetic nephropathy
KS Ayinde, OT Olaoba, B Ibrahim, D Lei, Q Lu, X Yin, TI Adelusi
Life sciences 261, 118455, 2020
182020
The in-vitro antioxidant properties and phytochemical constituents of Citrullus colocynthis methanolic extract
AO Owoade, A Adetutu, OS Olorunnisola, KS Ayinde
Elixir Appl. Botany 121, 51556-51562, 2018
112018
Are Hsp90 inhibitors good candidates against Covid-19?
CHI Ramos, KS Ayinde
Current protein and peptide science 22 (3), 192-200, 2021
92021
Functional foods’ bioactive components and their chemoprevention mechanism in cervical, breast, and liver cancers: A systematic review
JO Teibo, KS Ayinde, OT Olaoba, TI Adelusi, TKA Teibo, MV Bamikunle, ...
Functional Foods in Health and Disease 11 (11), 559-585, 2021
82021
Chemo-preventive roles of medicinal foods against environmental carcinogens-induced cancers
JO Teibo, OA Akinfe, AS Olagunju, FG Olorunfemi, TKA Teibo, OT Olaoba, ...
W Can Res J 8, e2102, 2021
62021
Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC
OT Olaoba, FC Ligali, ZO Alabi, AO Akinyemi, KS Ayinde
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (1), 188483, 2021
62021
Binding of SARS-CoV-2 protein ORF9b to mitochondrial translocase TOM70 prevents its interaction with chaperone HSP90
KS Ayinde, GMS Pinheiro, CHI Ramos
Biochimie 200, 99-106, 2022
52022
Is the new angel better than the old devil? Challenges and opportunities in CD47-SIRPα-based cancer therapy
OT Olaoba, KS Ayinde, OM Lateef, MO Akintubosun, KA Lawal, TI Adelusi
Critical Reviews in Oncology/Hematology, 103939, 2023
32023
The role of BFl-1 in cancer unravels inhibition mechanism
ZO Alabi, OT Olaoba, KS Ayinde, AO Akinyemi, TI Adelusi
Cancer Biology 9, 92-100, 2019
32019
Expression, purification, and characterization of SARS-CoV-2 ORF9b and the study of its interaction with human HSP90 and cytosolic TOM70= Expressão, purificação e …
KS Ayinde
[sn], 2022
2022
The Use of Immune System Cells for The Treatment of Metastatic Cancer: A Personalised Medicine Concept
OE Olajuyin, O Ayeotan, SA Ayinde, VT Olubiyi, GI Oke, SO Aluko
J Clin Med Res 3 (5), 1-18, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–13